Cellular Pathology Seminars

13:30 - 14:05

Does Dublin need a Centralised Pathology Service?


Review the current pathology service in Dublin. Examine the challenges involved in creating a centralised laboratory. Determine if centralisation has improved TAT and quality. Does Dublin need a centralised service?


Inductive approach. Direct non-disguised qualitative research, using semi-structured In-depth interviews(IDI). The data collected was divided into codes. The primary IDI’s reviewed the centralisation process. The secondary IDI’s provided a snap-shot of the current pathology service in Dublin.


Centralisation has resulted in improved patient care and better TAT. Dublin pathology laboratories are providing an excellent service. Sample volume is increasing. Staffing is a huge problem. Insufficient space is an issue for many laboratories.  Modernisation and LEAN initiatives need to be increased. 66% felt centralisation would help the service, via a Hub and Spoke model. Stakeholder agreement was seen as the greatest challenge.


Within the HSE there is little or no demand management. Staff skill-mix needs to be explored. Space and the locations of these laboratories in hospitals have restricted the potential for expansion & greater modernisation.

Examination of two centralised laboratories has shown improved patient care through standardisation, improved TAT and greater efficiencies. Proving that centralisation if well designed, does work.


14:05 - 14:40

Histopathology Reporting by Scientists – A UK Experience

In 2012 the RCPath and IBMS launched a pilot project in the UK, involving the reporting of gastrointestinal and gynaecological histopathological specimens by Biomedical Scientists.  Six years on and this is now a formal conjoint qualification, comprising four stages which mimic the training of medical histopathology trainees at an equivalent level to FRCPath part II.  Currently, two scientists have completed the training programme and are able to independently report specimens alongside Consultant Histopathologist colleagues, whilst more than fifty scientists around the UK are in various stages of the programme.  This presentation documents the experiences of a UK trainee, discussing the work involved to gain the qualification, including the structure of training and assessment at each stage. Studying for and gaining the qualification has led to numerous challenges, and these will be explored. The reasons, benefits and opportunities for departments employing reporting scientists will also be considered.  Finally, the presentation will demonstrate the achievements of the last six years, consider where the qualification might lead for Healthcare Scientists and the next steps in the development of this new qualification.


  • Dr Jo Horne Advanced Practitioner Healthcare Scientist - University Hospital Southampton
14:40 - 15:15

Fully Digital @Leeds: The First Year

Leeds Teaching Hospitals NHS has formed an exciting collaborative partnership with Leica biosystems for an evidence based, full deployment of digital pathology. We currently scan over 20% of all laboratory slides for primary digital diagnosis, and our well on our way to becoming "fully digital". We will share insights into the management, laboratory and clinical considerations involved in converting to digital practise, gleaned from the first year of this innovative project.


15:15 - 15:45

Naevi, Melanomas & I don’t Knows. The Good the Bad & the Ugly of Melanocytic Pathology